Biogen cuts profit view on higher M&A costs, Alzheimer’s drug expense
(Reuters) – Biogen on Wednesday cut its annual profit forecast, which slipped below Wall Street expectations, due to higher costs…
(Reuters) – Biogen on Wednesday cut its annual profit forecast, which slipped below Wall Street expectations, due to higher costs…
(Reuters) – A bipartisan group of U.S. lawmakers want the Biden administration to hike tariffs on Chinese-made vehicles and investigate…
(Reuters) – Israel-based Teva Pharmaceutical Industries (NYSE:TEVA), the world’s largest generic drugmaker, said on Wednesday production in Israel is largely…
(Reuters) – JPMorgan on Wednesday said it is teaming up with Bpifrance to invest around $60 million in private investment…
Circle Internet Financial Ltd., the issuer of the globally recognized USDC stablecoin, is reportedly considering an initial public offering (IPO)…
Starbucks Corp (NASDAQ:SBUX). shares experienced a minor downturn on Tuesday, ending a three-day winning streak. The company’s stock fell by…
U.S. stocks edged higher on Wednesday, setting the indexes on a path to extend their longest winning streak in two…
(Reuters) – The Swiss National Bank responded on Wednesday to the U.S. Treasury removing Switzerland from its monitoring list of…
(Reuters) – The Indian rupee will trade near record lows against the dollar over the coming months, according to a…
(Reuters) – Box office smash “Barbie” helped Warner Bros Discovery (NASDAQ:WBD) top quarterly profit estimates, but the effect of two…